We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RPT
2751
Rithm Property Trust
RPT
$93.7M
| $139K | ﹤0.01% |
6,094
-14,433
| -70% | -$405K |
|
2752
Diana Shipping
DSX
$301M
| $138K | ﹤0.01% |
47,770
-148,293
| -76% | -$442K |
|
|
LILM
2753
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $135K | ﹤0.01% |
141,041
-570,763
| -80% | -$530K |
|
|
PFIE
2754
DELISTED
Profire Energy, Inc
PFIE
| $133K | ﹤0.01% |
71,941
-133,249
| -65% | -$211K |
|
|
CLLS
2755
Cellectis
CLLS
$285M
| $132K | ﹤0.01% |
49,880
-2,367
| -5% | -$6.55K |
|
2756
Ginkgo Bioworks
DNA
$521M
| $131K | ﹤0.01% |
2,829
-2,902
| -51% | -$150K |
|
|
LICY
2757
DELISTED
Li-Cycle Holdings Corp.
LICY
| $131K | ﹤0.01% |
15,902
-142,317
| -90% | -$640K |
|
2758
Mistras Group
MG
$512M
| $129K | ﹤0.01% |
+13,532
| New | +$113K |
|
2759
1-800-Flowers.com
FLWS
$258M
| $128K | ﹤0.01% |
11,800
| – | – |
|
2760
Wolverine World Wide
WWW
$1.55B
| $127K | ﹤0.01% |
11,344
-70,868
| -86% | -$656K |
|
2761
Carter Bankshares
CARE
$731M
| $127K | ﹤0.01% |
+10,040
| New | +$137K |
|
2762
Ribbon Communications
RBBN
$383M
| $125K | ﹤0.01% |
39,112
-6,735
| -15% | -$20.5K |
|
|
MTLS
2763
Materialise
MTLS
$396M
| $125K | ﹤0.01% |
23,701
-17,863
| -43% | -$100K |
|
2764
Ovid Therapeutics
OVID
$491M
| $124K | ﹤0.01% |
+40,669
| New | +$136K |
|
2765
BRC Inc
BRCC
$250M
| $123K | ﹤0.01% |
+28,849
| New | +$120K |
|
2766
Cardiff Oncology
CRDF
$77.2M
| $123K | ﹤0.01% |
22,967
-7,700
| -25% | -$20.5K |
|
2767
Sensus Healthcare
SRTS
$50.5M
| $123K | ﹤0.01% |
32,250
-13,680
| -30% | -$49.6K |
|
2768
Riskified
RSKD
$716M
| $122K | ﹤0.01% |
22,479
-34,143
| -60% | -$162K |
|
|
VLD
2769
DELISTED
Velo3D, Inc.
VLD
| $121K | ﹤0.01% |
7,573
+5,943
| +365% | +$67.1K |
|
2770
Cognyte Software
CGNT
$680M
| $121K | ﹤0.01% |
14,600
-98,387
| -87% | -$698K |
|
2771
Globalstar
GSAT
$10.8B
| $120K | ﹤0.01% |
5,460
+813
| +17% | +$19.7K |
|
2772
Telesat
TSAT
$897M
| $120K | ﹤0.01% |
14,076
-11,344
| -45% | -$107K |
|
2773
Eton Pharmaceutcials
ETON
$1.22B
| $119K | ﹤0.01% |
31,790
-20,710
| -39% | -$90.4K |
|
2774
BARK
BARK
$101M
| $119K | ﹤0.01% |
+4,788
| New | +$105K |
|
|
BFIN
2775
DELISTED
BankFinancial
BFIN
| $118K | ﹤0.01% |
11,270
-2,000
| -15% | -$20.6K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.